Supply Chain

The price of U.S. cancer drugs after they hit the market was not affected by new competition, new supplemental FDA approvals or new off-label indications, according to a study published in the Journal of Clinical Oncology.

Pharmacists are taking on a much larger role than ever before in hospitals' strategic initiatives.

"Every day, hospitals across the country receive shipments of critical medications and pharmaceutical products they need to treat patients," says Erin Horvath, senior vice president of distribution services at AmerisourceBergen.

Merck & Co. released its third quarter earnings results Oct. 27. The company posted $10.32 billion in sales, down 2 percent from the $10.54 billion it reported during the same period last year.

Here are seven drug and medical device companies that made headlines in the past week.

While the healthcare industry is full of speculation over Amazon's potential entrance into the pharmacy market, one analyst believes the retailer may be more interested in the medical device market, reports CNBC.

Here are seven articles Becker's Hospital Review published in the last week, including a survey highlighting employers' perceptions of pharmacy benefit managers and Pfizer's plans to auction off its consumer health unit.

Amazon has slowly acquired more than 10 wholesale pharmacy licenses from state boards in the past year, fueling rumors over the retailer's potential entrance into the pharmaceutical supply chain, according to the St. Louis Post-Dispatch.

The FDA reportedly hired Nina Devlin, EpiPen maker Mylan's head of global communications, to serve as a senior communications adviser in the agency, according to The Hill.

Many U.S. employers are concerned about their pharmacy benefit manufacturer's level of transparency, contract complexity and rebate process, according to a report conducted by Benfield on behalf of the National Pharmaceutical Council.